News

Jake Philip, CEO of Biolase, said: “While we have had a number of recent successes in laser and consumable patents and global product launches, this is our first

The initiation of this single-arm open label observational safety study follows a successful pivotal Phase III study of Dyloject in patients with postoperative abdominal pain. Additionally, the company

The opening of additional sites in Germany is intended to compensate for a lower than expected patient enrollment rate thus far in Sweden. These sites have been added

Used in conjunction with the company’s proprietary CellOptics platform, a robotic microscopy system, oncoFISH cervical provides the physician, while still adhering to current practice guidelines, with an assessment

The approved EraGen molecular diagnostic tests are performed on the company’s MultiCode-RTx real-time polymerase chain reaction (PCR) system. The MultiCode-RTx system reportedly simplifies and enhances traditional real-time PCR

The acquisition of Orthos represents Atrium’s second Netherlands-based acquisition for 2008. Atrium has previously announced the acquisition of MCO Health, a manufacturer and distributor of nutritional supplements. AOV

Teva is manufacturing and distributing the product, under license, as part of a license and distribution agreement entered into between Teva and Exela PharmSci, a Reston, Virginia pharmaceutical

The trial was designed to evaluate the effect of SCV-07 on hepatitis C viral load, as well as on other measures of immune response. SCV-07 demonstrated activity in

Patients in this open label study will be randomized into two dose groups of 28 patients each and will receive a total of six infusions of ofatumumab in